Propofol-induced anesthesia in mice is mediated by γ-aminobutyric acid-A and excitatory amino acid receptors

Anesthesia and Analgesia

Volumn 97, Issue 2, 2003, Pages 424-429

  Irifune, Masahiro ^a   Takarada, Tohru ^a   Shimizu, Yoshitaka ^a   Endo, Chie ^a   Katayama, Sohtaro ^a   Dohi, Toshihiro ^a   Kawahara, Michio ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALLYLGLYCINE; ANESTHETIC AGENT; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BICUCULLINE; DIAZEPAM; DIZOCILPINE; EXCITATORY AMINO ACID RECEPTOR; FLUMAZENIL; KAINIC ACID; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; PROPOFOL;

ANESTHESIA MECHANISM; ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; GENERAL ANESTHESIA; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RIGHTING REFLEX;

EID: 0042848838     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000059742.62646.40     Document Type: Article

References (28)

1. Peduto VA, Concas A, Santoro G, et al. Biochemical and electrophysiologic evidence that propofol enhances GABAergic transmission in the rat brain. Anesthesiology 1991;75:1000-9.
2. A receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology 1993;79:781-8.
3. A receptors expressed by Xenopus oocytes: lack of involvement of intracellular calcium. J Pharmacol Exp Ther 1992;263:569-78.
4. Irifune M, Sugimura M, Takarada T, et al. Propofol anaesthesia in mice is potentiated by muscimol and reversed by bicuculline. Br J Anaesth 1999;83:665-7.
5. Orser BA, Bertlik M, Wang L-Y, MacDonald JF. Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br J Pharmacol 1995;116:1761-8.
6. Yamakura T, Sakimura K, Shimoji K, Mishina M. Effects of propofol on various AMPA-, kainate- and NMDA-selective glutamate receptor channels expressed in Xenopus oocytes. Neurosci Lett 1995;188:187-90.
7. A receptor-mediated inhibition. Anesthesiology 2000;92: 1067-73.
8. Löscher W. Comparative assay of anticonvulsant and toxic potencies of sixteen GABAmimetic drugs. Neuropharmacology 1982;21:803-10.
9. Khan GM, Smolders I, Ebinger G, Michotte Y. Flumazenil prevents diazepam-elicited anticonvulsant action and concomitant attenuation of glutamate overflow. Eur J Pharmacol 2000;407:139-44.
10. Irifune M, Shimizu T, Nomoto M, Fukuda T. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice. Pharmacol Biochem Behav 1995;51:291-6.
11. Shimizu-Sasamata M, Kawasaki-Yatsugi S, Okada M, et al. YM90K: pharmacological characterization as a selective and potent α-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist. J Pharmacol Exp Ther 1996;276: 84-92.
12. Orlowski M, Reingold DF, Stanley ME. D- and L-stereoisomers of allylglycine: convulsive action and inhibition of brain L-glutamate decarboxylase. J Neurochem 1977;28:349-53.
13. Chapman AG, Westerberg E, Premachandra M, Meldrum BS. Changes in regional neurotransmitter amino acid levels in rat brain during seizures induced by L-allylglycine, bicuculline, and kainic acid. J Neurochem 1984;43:62-70.
14. Horton RW, Chapman AG, Meldrum BS. Regional changes in cerebral GABA concentration and convulsions produced by D and by L-allyglycine. J Neurochem 1978;30:1501-4.
15. A receptor agonistic properties of ketamine: convulsive and anesthetic behavioral models in mice. Anesth Analg 2000;91:230-6.
16. Charney DS, Mihic SJ, Harris RA. Hypnotics and sedatives. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill, 2001:399-427.
17. Worms P, Depoortere H, Lloyd KG. Neuropharmacological spectrum of muscimol. Life Sci 1979;25:607-14.
18. Bansinath M, Shukla VK, Turndorf H. Propofol modulates the effects of chemoconvulsants acting at GABAergic, glycinergic, and glutamate receptor subtypes. Anesthesiology 1995;83:809-15.
19. Moreau J-L, Pieri L, Prud'hon B. Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants. Br J Pharmacol 1989;98:1050-4.
20. Ferkany JW, Borosky SA, Clissold DB, Pontecorvo MJ. Dextromethorphan inhibits NMDA-induced convulsions. Eur J Pharmacol 1988;151:151-4.
21. Leander JD. Tricyclic antidepressants block N-methyl-D-aspartic acid-induced lethality in mice. Br J Pharmacol 1989;96:256-8.
22. Parada-Turska J, Turski WA. Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology 1990;29:1111-6.
23. Irifune M, Shimizu T, Nomoto M, Fukuda T. Ketamine-induced anesthesia involves the N-methyl-D-aspartate receptor-channel complex in mice. Brain Res 1992;596:1-9.
24. Zhang WQ, Rogers BC, Tandon P, et al. Systemic administration of kainic acid increases GABA levels in perfusate from the hippocampus of rats in vivo. Neurotoxicology 1990;11:593-600.
25. Ding R, Asada H, Obata K. Changes in extracellular glutamate and GABA levels in the hippocampal CA3 and CA1 areas and the induction of glutamic acid decarboxylase-67 in dentate granule cells of rats treated with kainic acid. Brain Res 1998;800:105-13.
26. Turski L, Klockgether T, Schwarz M, Sontag K-H. Unusual interactions of excitatory amino acid receptor agonists: α- and β-kainate antagonize motor responses to N-methyl-D-aspartate in rodents. Neuroscience 1987;20:285-92.
27. Goldberg O, Teichberg VI. Peptides derived from kainic acid as antagonists of N-methyl-D-aspartate-induced neuroexcitation in rat brain. Neurosci Lett 1985;60:101-5.
28. Hudspith MJ. Glutamate: a role in normal brain function, anaesthesia, analgesia and CNS injury. Br J Anaesth 1997;78:731-47.